SCHEMBL3773018

SCHEMBL3773018

Cc1n[nH]c2ccnc(Nc3ccc(Cn4cncn4)cc3)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
CYP19A1 P11511 3/20 0.39
FLT1 P17948 1/20 0.39
KDR P35968 1/20 0.39
LRRK2 Q5S007 4/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ACHE P22303 1/20 0.36
EGFR P00533 1/20 0.36
KLKB1 P03952 1/20 0.36
CTSK P43235 1/20 0.35
GRM4 Q14833 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2C P18825 1/20 0.34
HTR1D P28221 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766209 0.88 JAK2 (0.41) CYP1A2CYP19A1HDAC1HDAC6EGFR
SCHEMBL3775217 0.83 CYP11B1 (0.48) CYP1A2CYP1A1CYP1B1CYP19A1LRRK2
SCHEMBL13006149 0.82 LRRK2 (0.42) CYP19A1LRRK2EGFRGRM4
SCHEMBL13005931 0.81 MAPK10 (0.44) CYP1A2LRRK2GRM4CYP2D6CYP2C19
SCHEMBL3764126 0.81 GAA (0.38) CYP19A1FLT1KDRLRRK2EGFR
Hydrochloric Acid SCHEMBL383082 0.81 MAPK10 (0.43) CYP1A2LRRK2GRM4CYP2D6CYP2C19
SCHEMBL3775083 0.79 AXL (0.46) LRRK2
SCHEMBL3775101 0.78 TLR8 (0.38) LRRK2CYP3A4CYP2D6
SCHEMBL3770171 0.77 PLK4 (0.46) FLT1LRRK2EGFR
SCHEMBL3775370 0.76 LRRK2 (0.63) CYP1A2FLT1KDRLRRK2GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170320870-A1 COMPOUNDS MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2017-11-09 US disclosed
US-20170320870-A1 COMPOUNDS MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2017-11-09 US disclosed
US-20170320870-A1 COMPOUNDS MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2017-11-09 US disclosed
EP-2408772-B1 COMPOUNDS MEDICAL RES COUNCIL TECHNOLOGY (GB) 2015-07-01 EP disclosed
US-20100317646-A1 COMPOUNDS MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170320870-A1 COMPOUNDS CBR3, CNR1, HCAR3 CYP1A2 613/4885CYP1A1 284/4885CYP1B1 349/4885
US-20100317646-A1 COMPOUNDS CBR3, CNR1, HCAR3 CYP1A2 608/4885CYP1A1 294/4885CYP1B1 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.